MOTPOLY XR (NDA216185)- (100MG,150MG,200MG)

Generic Name	LACOSAMIDE	Innovator	AUCTA
Dosage	100MG,150MG,200MG
ParaIV Filing	No	505(b)2 Filing	Yes
Last Patent Expiry	2040-Jun-05	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	None
GAIN Expiry	None	Drug Complexity	No
Indication	MOTPOLY XR is indicated for the treatment of partial-onset seizures in adults and in pediatric patients weighing at least 50 kg.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
0	0	0

Other Developers

Total Other Developers	None

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
100MG	**	**	-	-	-
150MG	**	**	-	-	-
200MG	**	**	-	-	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
No	0

Manufacturing Details of MOTPOLY XR